| Article ID | Journal | Published Year | Pages | File Type |
|---|---|---|---|---|
| 6191672 | European Journal of Surgical Oncology (EJSO) | 2015 | 9 Pages |
Abstract
Adjuvant chemotherapy delay adversely impacts colonic and rectal cancer survival. Efforts to prevent complications such as reoperation and to improve access to chemotherapy services, will improve survival in this patient cohort.
Related Topics
Health Sciences
Medicine and Dentistry
Oncology
Authors
S. Nachiappan, A. Askari, R. Mamidanna, A. Munasinghe, A. Currie, J. Stebbing, O. Faiz,